←
Umang Jaipuria16,989 posts
Umang Jaipuria avatar

Umang Jaipuria

@umang

building a postmodern services biz. ex- eng / pm / head of some orgs @ amzn, twtr, plaid, znga. leave me anon feedback: bit.ly/3Xjk3dg

◷ Joined April 2008▧ 1,179 Photos and videos
Umang Jaipuria avatar
Umang Jaipuria@umang·Jun 9

Built a thing I've started living in recently, and open sourced it: github.com/umangjaipuria/red… My interaction with agents has moved mostly into docs. They write them, we discuss, they edit and on and on. Sometimes they build what's in the doc, other times the doc is what ships. And thanks to Thariq and the Claude Code team, these docs are now beautiful html. But I didn't have an easy way to - give feedback on specific parts - ask questions about a paragraph - ask it to simplify something - or add more detail (collapsible sections in html are chef's kiss) Redline lets you leave comments in html docs, and lets agents read those comments and reply as they edit the doc. Runs locally, state stored in your html files, easily checked into your repo. No db, no 3rd party server, nothing. It was fun building Redline - I was the user and the builder simultaneously. Literally was giving stream-of-conscious feedback to Codex (sometimes Claude Code) in one window while using the app with another CC instance as we worked on a fairly complex doc.

Post attachment
Umang Jaipuria avatar
Umang Jaipuria@umang·18h

Fascinating on multiple counts What other intervention has reduced need for care (and spend) by this much? How is it that the cash price for this is lower than the employer insurance price? What other medical spend would be cheaper if you paid out of pocket? What do the numbers look like for employers that self-insure? Have a bunch of spare ChatGPT usage, perhaps time to burn them on GPT Pro…

CVS just put a number on the GLP-1 break-even question. Using Aetna claims, they estimate that at ~$350/month, medical savings roughly offset the drug cost over 3 years. Compared with matched non-users, GLP-1 users had: - 10-12% fewer ER visits in years 1 and 2 - 14% lower odds of a major cardiovascular event - 34-42% fewer hospitalizations among those still on the drug at year 3 At today’s employer prices (~$617-766/mo), plans saved $9,400 per person on medical but spent $13,300 more on Rx. Net: +$3,900. The interesting part: cash prices (~$299-349) and Medicare’s $245 pilot price are already below CVS’s break-even. The barrier isn’t what these drugs can be sold for. It’s what employers are paying. Family coverage now costs $28,303 a year (KFF). That’s why employers are dropping GLP-1s, not because the drugs don’t work. At ~$350/mo, they wouldn’t have to choose. A few call outs: it's a CVS white paper... (insert disclaimers). Observational. Diabetes and obesity pooled. The year-3 group (n≈4,000) is people who stayed on, who may differ from those who stopped. And CVS has a seat at this negotiating table. Affordability drives access.

Umang Jaipuria avatar
Umang Jaipuria@umang·19h

interesting how Claude has been building Artifcats for months, and the moment ChatGPT launches Spaces, every agent product now has their own Spaces equivalent. lesson in branding? or something else?

Umang Jaipuria avatar
Umang Jaipuria@umang·Nov 17

who’s working on aesthetics that will keep up with the technological frontier? we’re are talking to computers, have a universal translator, about to go boldly into space… we CANNOT take mid century modern and athleisure into this brave new world

Mitko avatar
⟳ Umang Jaipuria retweeted
Mitko@themitak·Nov 17

Announcing Warm Intros, by Pioneer: know who talk to this week, and who can introduce you. usepioneer.ai

0:53
Umang Jaipuria avatar
Umang Jaipuria@umang·Nov 16

“Telework adoption explains the decline in (new graduate) employment better than AI exposure in our model using public data. And our own Stripe data suggests a negative relationship between regional spend on WFH proxies and growth in youth employment.”

New from @Stripe Economics: employment of young college grads is weaker than normal. Much of the debate is around AI's impact. But evidence is growing that work-from-home is a major factor, which we find in public data & our own Stripe data. 🧵 stripeeconomics.com/p/ai-wor… /1

Andrea avatar
⟳ Umang Jaipuria retweeted
Andrea@andreaesposito·Nov 14

For all but a vanishingly brief instant near the dawn of history, the word ‘ship’ will mean ‘spaceship.’ - Arthur C. Clarke

0:25
Umang Jaipuria avatar
Umang Jaipuria@umang·Nov 16

when a model is stuck in regulatory trials and approvals does the lab get to keep using that model? is that not anti-competitive?

roon@tszzlNov 16

people have little understanding of how much the federal government is already involved in the ai industry. for example if there’s a new model you need to convince the feds that new model is safe before launching it or men with proverbial guns and export control bans show up

Umang Jaipuria avatar
Umang Jaipuria@umang·Nov 15

who will watch the watchmen

The articles backtracked from their original incendiary, and now clearly false, claims to something more like "Jensen did lawful things that powerful people didn't like". It still appears the original claims came from a single competing Big Tech lobbyist. The reporting successfully disrupted corporate governance processes, with a running cost of $1.8 trillion in losses to American pension funds and shareholders. Here's what I fear is being lost in these articles: The proper interface between government and private citizens and their corporations is rule of law. Laws are passed, and if wrongdoing as alleged, then there's due process: an investigation followed by facts and evidence presented in open court. Due process should happen here: let the facts come out whole, and not as a trickle of dubious claims. Press takedowns full of sketchily sourced claims and backtracking narratives are not the way. It's what we see outside of the free world, and is no model for The United States of America. In particular, if the Jensen takedown succeeds on the basis of these journalistic failings, which is not by any means certain as Sam Altman's case shows, then it foreshadows an economically and institutionally ruinous new playbook to be adopted with no end in sight. Imagine a weekly stream of takedowns emerging from opportunistic alignments between corporate lobbyists and political interests which, given the new partisan split between the executive and legislative branches, will attack in all directions, undermining not only the US economy but American leadership in the world. I hope cooler heads prevail this coming week as they did not on Thursday November 12. And I urge anyone who happened to oppose Jensen, open models, and the underlying trade policies in question, to recognize that this isn't a win for "team regulation". It's a change in the game from a transparent rules-based one to a sinister new form centered around politicans and lobbyists.

Riva avatar
⟳ Umang Jaipuria retweeted
Riva@rivatez·Nov 14

that SpaceX did that while the government shut everything down due to legacy software issues (and then demanded $50bn in emergency funding) is too fantastical even for the most ardent Randian the sky shines bright with freedom

Umang Jaipuria avatar
Umang Jaipuria@umang·Nov 15

hey @muse - aren’t ya glad i was too busy today to follow your advice to touch to live wires together?

Post attachment
Umang Jaipuria avatar
Umang Jaipuria@umang·Nov 14

Somehow the algo has dropped me into the Ramayana corner of X and I’m seeing all these AI generated videos of various scenes from the epic, and I’m here for it. All of which seem so much better than the trailer of the new movie, which reeks of Bollywood mediocrity and plagiarism.